Early research (Phase 1)Study completedNCT04961359
What this trial is testing
Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2(COVID-19) Phase I Clinical Trial (3~17 Years Old)
Who this might be right for
Coronavirus
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 75